Atomoxetine compared with placebo for adult ADHD over 38 weeks
About this title
Read the official source — NCT00190775Researchers compared Atomoxetine Hydrochloride and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.
Understand this study
What did researchers investigate?
Researchers compared Atomoxetine Hydrochloride and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.
Who was this study for?
This study was for people with ADHD. Listed age limits: from 18 years. Other eligibility criteria applied.
- Listed locations
- Irvine and 20 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 502
- Sponsor
- Eli Lilly and Company
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT00190775
- Official title
Show the full official title
A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder: With a Secondary Examination of Impact of Treatment on Family Functioning
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Irvine, United States · Gainesville, United States · Tampa, United States
18 more locations
- Atlanta, United States
- Libertyville, United States
- Indianapolis, United States
- Bardstown, United States
- Baltimore, United States
- Rochester Hills, United States
- Troy, United States
- Mount Kisco, United States
- Chapel Hill, United States
- Cleveland, United States
- Toledo, United States
- Media, United States
- Houston, United States
- Salt Lake City, United States
- Herndon, United States
- Middleton, United States
- West Allis, United States
- Santurce, Puerto Rico
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared Atomoxetine Hydrochloride and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.
Who is behind this study?
The study sponsor is Eli Lilly and Company.
Did this study involve medication?
Yes. The study involved medication, including Atomoxetine Hydrochloride and Placebo.
Who was this study for?
This study was for people with ADHD. Listed age limits: from 18 years. Other eligibility criteria applied.
